Details for New Drug Application (NDA): 062045
✉ Email this page to a colleague
NDA 062045 describes MYCO-TRIACET II, which is a drug marketed by Teva and is included in two NDAs. Additional details are available on the MYCO-TRIACET II profile page.
The generic ingredient in MYCO-TRIACET II is nystatin; triamcinolone acetonide. There are eight drug master file entries for this compound. Twenty-two suppliers are listed for this compound. Additional details are available on the nystatin; triamcinolone acetonide profile page.
The generic ingredient in MYCO-TRIACET II is nystatin; triamcinolone acetonide. There are eight drug master file entries for this compound. Twenty-two suppliers are listed for this compound. Additional details are available on the nystatin; triamcinolone acetonide profile page.
Summary for 062045
| Tradename: | MYCO-TRIACET II |
| Applicant: | Teva |
| Ingredient: | nystatin; triamcinolone acetonide |
| Patents: | 0 |
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | OINTMENT;TOPICAL | Strength | 100,000 UNITS/GM;0.1% | ||||
| Approval Date: | Nov 26, 1985 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
